Browse Related Topics For:

ANDA

292
Pharmaceutical Industry
290
Patents
260
Pharmaceutical Patents
239
Patent Infringement
238
Generic Drugs
237
Patent Litigation
138
FDA
135
Hatch-Waxman
133
Prescription Drugs
61
Patent-in-Suit
51
Mylan Pharmaceuticals
40
Actavis Inc.
40
Teva Pharmaceuticals
38
FTC
37
Reverse Payment Settlement Agreements
37
SCOTUS
33
Obviousness
31
Biotechnology
31
FTC v Actavis
29
Personal Jurisdiction
27
Patent Invalidity
26
Apotex
26
Intellectual Property Protection
25
Merck
21
AstraZeneca
21
Claim Construction
21
Prior Art
20
Appeals
20
Watson Pharmaceuticals
19
Eli Lilly
17
Orange Book
16
Pay-For-Delay
16
Sandoz
15
Antitrust Litigation
15
Infringement
15
Motion to Dismiss
15
On-Sale Bar
14
Novartis
13
Allergan Inc
13
Noninfringement
12
BPCIA
12
Declaratory Judgments
12
FDCA
12
Jurisdiction
12
Manufacturers
12
Patent Trial and Appeal Board
12
Sherman Act
11
America Invents Act
11
Cephalon
11
FDA Approval
11
Hospira
11
Induced Infringement
11
Inter Partes Review (IPR) Proceeding
11
Labeling
11
Patent Applications
11
Pfizer
11
Popular
11
USPTO
10
Biosimilars
10
Corporate Counsel
10
Par Pharmaceutical
10
Roxane Laboratories
9
Bayer
9
DaimlerChrysler v Bauman
9
Healthcare
9
Summary Judgment
8
Amgen
8
Safe Harbors
8
Specific Jurisdiction
7
Anti-Competitive
7
Antitrust Violations
7
Biologics
7
Endo Pharmaceuticals
7
Generic
7
GlaxoSmithKline
7
Janssen Pharmaceuticals
6
AbbVie
6
Class Action
6
Commercial Marketing
6
DaimlerAG
6
Doctrine of Equivalents
6
Federal Rule 12(b)(6)
6
Gilead Sciences
6
Life Sciences
6
Medical Devices
6
Method Claims
6
Minimum Contacts
6
Patent-Eligible Subject Matter
6
Prometheus
6
Settlement
6
Standing
6
Warner Chilcott
6
Written Descriptions
5
Antitrust Provisions
5
Drug Pricing
5
Exclusivity
5
Medicare
5
Orphan Drugs
5
Otsuka Pharmaceutical
5
Product Exclusivity
5
Product Labels
5
REMS
5
Rule-of-Reason Analysis
4
Boehringer
4
Direct Infringement
4
Forest Laboratories
4
General Jurisdiction
4
HHS
4
Intellectual Property Litigation
4
Legislative Agendas
4
Medicare Modernization Act
4
No-AG Agreement
4
Permanent Injunctions
4
Physicians
4
Product Hopping
4
Reversal
4
Spectrum
4
Subject Matter Jurisdiction
4
Suppliers
3
Affordable Care Act
3
Allergan v Sandoz
3
Amarin
3
Article III
3
Bristol-Myers Squibb
3
Citizen Petitions
3
Classen Immunotherapies
3
CLS Bank v Alice Corp
3
CMS
3
Counterclaims
3
Disgorgement
3
Elan Pharmaceuticals
3
Enablement Inquiries
3
Estoppel
3
Failure To Warn
3
Forum Shopping
3
Fresenius
3
Genzyme
3
Jazz Pharmaceuticals
3
Limelight v Akamai
3
Markman Hearing
3
Medicaid
3
Medicare Prescription Drug Improvement and Modernization Act (MMA)
3
Mergers
3
Patent Dance
3
Patients
3
Preliminary Injunctions
3
RanBaxy
3
Real Party in Interest
3
Reverse Payments
3
Sandoz v Amgen
3
Shire Development v Watson
3
SmithKline Beecham
3
Takeda Pharmaceuticals
3
Third-Party Relationships
3
Trump Administration
3
Unfair Competition
2
Antitrust Investigations
2
Aurobindo Pharmaceuticals
2
Bausch & Lomb
2
Biopharmaceutical
2
Brand
2
Cadence Pharmaceuticals Inc.
2
Cadillac Tax
2
CAFC
2
Cancer
2
Chevron Deference
2
De Novo Standard of Review
2
Disclosure Requirements
2
Discovery
2
Dismissals
2
Divided Infringement
2
Draft Guidance
2
En Banc Review
2
Extortion
2
Federal Budget
2
Federal Rule 12(b)(1)
2
Federal Rules of Civil Procedure
2
Forum
2
Forum Selection
2
Health Care Providers
2
Health Insurance
2
Indefiniteness
2
Injunctions
2
Inter Partes Reexamination
2
Interlocutory Appeals
2
Inventors
2
IRS
2
ITC
2
Laches
2
Lanham Act
2
Malicious Prosecution
2
Monopolization
2
Motion To Stay
2
Notice Requirements
2
Nunc Pro Tunc
2
OIG
2
Out-of-State Companies
2
OxyContin
2
Pleading Standards
2
Pleadings
2
PLIVA v Mensing
2
Preemption
2
Proposed Legislation
2
Putative Class Actions
2
Rebates
2
Reissue Patents
2
Remand
2
Reporting Requirements
2
Rulemaking Process
2
Sanofi
2
Sanofi-Aventis
2
Trademarks
2
Treatment Method Patents
2
TRO
2
Vaccinations
1
Abbott Laboratories
1
aBLA
1
Abstract Ideas
1
Abuse of Discretion
1
ACOs
1
Acquisitions
1
Administrative Procedure Act
1
Administrative Proceedings
1
Advertising
1
Affirmative Defenses
1
AHRQ
1
Akamai Technologies
1
Amazon
1
Ambiguous
1
Anti-SLAPP
1
Anti-Steering Rules
1
Antibiotics
1
Anticompetitive Behavior
1
Antitrust Conspiracies
1
Antitrust Injuries
1
App Developers
1
Arbitration
1
Arbitration Agreements
1
Artificial Intelligence
1
Assignments
1
Assignor Estoppel
1
Attorney-Client Privilege
1
Automatic Stay
1
Bifurcation
1
Big Data
1
Bipolar Disorder
1
Burden of Proof
1
CA Supreme Court
1
Cal Code of Civil Procedure
1
Carve Out Provisions
1
Causation
1
CDC
1
Certifications
1
Certiorari
1
CGMP
1
CHIP
1
Cipro
1
Cisco v CommilUSA
1
Civil Monetary Penalty
1
Claim Preclusion
1
Claims Limitations Period
1
Class Certification
1
Classification
1
Clear and Convincing Evidence
1
Clear Error Standard
1
CLIA
1
Clinical Laboratory Testing
1
Clinical Trials
1
Collateral Estoppel
1
Combination Products
1
Comment Period
1
Competition
1
Complex Litigation
1
Compliance
1
Confidentiality Agreements
1
Consent
1
Consent Order
1
Continuing Resolution
1
Contract Disputes
1
Contract Drafting
1
Copyright
1
Copyright Infringement
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Daiichi Sankyo
1
Damages
1
Debt Ceiling
1
Delaware General Corporation Law
1
Dell
1
Denial of Certiorari
1
Depositions
1
Direct Purchasers
1
Disclosure
1
Divestiture
1
DMCA
1
DOJ
1
DSCSA
1
Due Process
1
Duty to Deal
1
E-Filing
1
Employer Mandates
1
Enforcement Actions
1
Exemptions
1
Expert Testimony
1
Expert Witness
1
Failure To State A Claim
1
Fair Market Value
1
Fair Use
1
False Advertising
1
False Claims Act (FCA)
1
FD&C Act
1
FDASIA
1
Federal Civil Penalties Inflation Adjustment Act Improvements Act of 2015
1
Federal Jurisdiction
1
Final Written Decisions
1
First Amendment
1
Foreign Corporations
1
Foreign Defendants
1
Forum Non Conveniens
1
Genentech
1
Good Faith
1
Goodyear
1
Government Investigations
1
Hart-Scott-Rodino Act
1
Hedge Funds
1
HIV
1
Hoffman LaRoche
1
Home Healthcare Workers
1
Hospital Mergers
1
HRSA
1
Imminent Harm
1
Implied Consent
1
Indirect Infringement
1
Individual Mandate
1
Inducement
1
Information Reports
1
Innovation Act
1
Integra
1
International Arbitration
1
Internet of Things
1
Investigational New Drug Application (IND)
1
IP Assignment Agreements
1
Issue Preclusion
1
John Boehner
1
Joint Venture
1
Judge Stark
1
Judgment on the Pleadings
1
Justiciable Controversy
1
Leave to Amend
1
Lenz v Universal Music Corp.
1
License Agreements
1
Licensing Rules
1
Likelihood of Success
1
Lipitor
1
Litigation Privilege
1
Long Arm Statute
1
Luxembourg
1
Manufacturing Facilities
1
Marketing
1
Martin Shkreli
1
Mayo v. Prometheus
1
MDRP
1
Meaningful Use
1
Means-Plus-Function
1
Medicaid Expansion
1
Medical Device Tax
1
Medical Foods
1
Mensing
1
Minimum Wage
1
Misbranding
1
Mootness
1
Motion for Reconsideration
1
Motion to Amend
1
Motion to Transfer
1
Mylan Pharmaceuticals Inc v Acorda Theraputics Inc
1
New Guidance
1
New Trial
1
Nexium
1
NIH
1
Nintendo
1
Noerr-Pennington Doctrine
1
Nominations
1
Non-Compete Agreements
1
Non-Disclosure Agreement
1
Obama Administration
1
Off-Label Promotion
1
Off-Label Use
1
Offsets
1
Opioid
1
OTDP
1
Overpayment
1
Partial Summary Judgments
1
PATENT Act
1
Patent Agent Privilege
1
Patent Ownership
1
Patent Prosecution
1
Patent Reform
1
Patent Term Adjustment
1
Patent Term Extensions
1
Patent Trolls
1
Patent Validity
1
Patent-Misuse
1
Pending Legislation
1
Personalized Medicine
1
Petition For Rehearing
1
Petition for Writ of Certiorari
1
Pharmacies
1
Physician Medicare Reimbursements
1
Physician SGR Formula
1
Physician-Assisted Suicide
1
Post-Grant Review
1
Post-Market Approval
1
Premerger Notifications
1
Presumption of Validity
1
Prince
1
Proposed Regulation
1
Proposed Rules
1
Public Disclosure
1
Public Health Insurance Marketplace
1
Public Health Service Act
1
Public Interest
1
Public Meetings
1
Qui Tam
1
Registration Requirement
1
Research and Development
1
Research Tools
1
Restraining Orders
1
Restrictive Covenants
1
Royalties
1
Sales Contracts
1
Sanctions
1
SCA Hygiene Products Aktiebolag v First Quality Baby Products
1
SEC
1
Secretary of HHS
1
Section 102
1
Section 337
1
Section 340B
1
Set-Asides
1
Settlement Agreements
1
Sham Citizen Petitions
1
Sham Litigation Exception
1
SNDAs
1
Social Services
1
Software Patents
1
Split of Authority
1
Standard Essential Patents
1
Standard of Proof
1
Standard of Review
1
Startups
1
State Law Tort Claims
1
Statutory Authority
1
Subsidiaries
1
Substantial Evidence Standard
1
Takedown Notices
1
Tax Liability
1
The Common Rule
1
The Patent Act
1
Threshold Requirements
1
Tolling
1
Totality of Circumstances Test
1
Trade Secrets
1
Trademark Infringement
1
Trans-Pacific Partnership
1
Transfer of Title
1
Tyco
1
Unclean Hands
1
Universal Health Services Inc v United States ex rel Escobar
1
Vacated
1
Valeant
1
Validity
1
Wage and Hour
1
WIPO
1
Work Product Privilege
1
Wyeth
1
Young Lawyers
1
YouTube
Feedback? Tell us what you think of the new jdsupra.com!